The bacterial pathogen *Staphylococcus aureus* binds to host extracellular matrix proteins using a variety of cell-wall--anchored proteins ([@r1]). Among these, the fibrinogen (Fg)-binding microbial surface component recognizing the adhesive matrix molecule (MSCRAMM) protein clumping factor A (ClfA) is an important virulence factor of *S. aureus* involved in various infections ([@r2][@r3]--[@r4]). In addition, ClfA promotes bacterial attachment to plasma protein-coated biomaterials allowing the bacteria to colonize and form a biofilm ([@r5]). Vaccination with recombinant ClfA is protective against infection, and ClfA has been included as an antigen in a number of multivalent *S. aureus* vaccines currently in clinical trials ([@r2], [@r6], [@r7]). ClfA has an N-terminal A region composed of three separately folded subdomains: N1, N2, and N3. N2 and N3 form the minimum ligand-binding region and bind the carboxy-terminus of the γ-chain of Fg ([Fig. 1*A*](#fig01){ref-type="fig"} and refs. [@r8][@r9]--[@r10]) through a variation of the multistep "dock, lock, and latch" (DLL) mechanism ([@r11]) first described for the binding of the *Staphylococcus epidermidis* protein SdrG to Fg ([@r12]). The carboxy-terminus of the γ-chain of Fg docks in a ligand-binding trench located between subdomains N2 and N3. The DLL mechanism involves dynamic conformational changes of the adhesin that result in a greatly stabilized adhesin-ligand complex. The overall affinity of the interaction of ClfA with Fg is increased through interactions at a recently described second site that lies at the top of subdomain N3 outside of the DLL ligand-binding trench ([@r13]).

![Studying the ClfA--Fg interaction. (*A*) The N-terminal signal sequence (S) is followed by subdomains N1, N2, and N3 comprising the ligand-binding A region. At the junction between N2 and N3 is found a binding trench in which the ligand (red) inserts and is locked in place. A flexible serine-aspartate repeat region links region A to the C-terminal Wall (W) spanning region and the sorting sequence. The LPXTG motif allows anchoring of the protein to cell-wall peptidoglycan by sortase A. (*B*) Optical microscopy images of *S. aureus* bacteria expressing or not full-length ClfA \[ClfA^(+)^ and ClfA^(−)^ cells\] following incubation with Fg-conditioned substrates. (*C*) Force nanoscopy of the ClfA--Fg interaction: (*Left*) SCFS; (*Right*) SMFS. For clarity, the N1 domain of ClfA is not shown.](pnas.1718104115fig01){#fig01}

Antibiotic treatments have proven to be less and less effective over the years due to the emergence of multidrug-resistant strains ([@r14], [@r15]). Therefore, there is great interest in developing alternative strategies to fight bacterial infections ([@r15], [@r16]). An appealing approach is the use of antiadhesion compounds to block cell adhesion and biofilm development ([@r17]). A well-known example is the use of cranberry juice to treat urinary tract infections by uropathogenic *Escherichia coli* bacteria ([@r18]). The development of novel antiadhesion therapeutics targeting ClfA requires a detailed understanding of the ligand-binding mechanisms of this adhesin.

An interesting trait of ClfA is its ability to favor adhesion to blood proteins at high shear stress ([@r19][@r20]--[@r21]). Despite the biological relevance of such stress-induced adhesion, the underlying molecular mechanism has not yet been elucidated. We hypothesized that the interaction of ClfA with Fg might strengthen through a force-sensitive mechanism. To test this idea, we measured the strength of the bond between ClfA and immobilized Fg at various tensile loads, using atomic force microscopy (AFM) ([Fig. 1*C*](#fig01){ref-type="fig"}) ([@r22][@r23][@r24]--[@r25]). We found that, while the ClfA--Fg bond is weak at low applied force, the bond strength is dramatically increased at high force. These results provide compelling evidence that ClfA functions as a force-sensitive molecular switch that regulates the strength of adhesion of *S. aureus* to protein-conditioned biomaterials, thus emphasizing the role that physical forces play in activating the function of bacterial adhesins. This study holds promise for the design of antibacterial agents with the capacity to inhibit *S. aureus* adhesion at high shear rate.

Results {#s1}
=======

*S. aureus* Strongly Binds to Immobilized Fibrinogen. {#s2}
-----------------------------------------------------

To investigate ClfA--Fg interactions in living bacteria, we used *S. aureus* SH1000 *clfA clfB fnbA fnbB* \[hereafter called *S. aureus* ClfA^(−)^ cells; ref. [@r26]\] and the same strain transformed with a plasmid expressing the entire *clfA* gene \[ClfA^(+)^ cells\]. Fg was immobilized on solid substrates using *N*-hydroxysuccinimide (NHS) surface chemistry. Optical microscopy images confirmed that ClfA^(+)^ cells adhered in large amounts to Fg-coated substrates, while no adhesion was seen with ClfA^(−)^ cells ([Fig. 1*B*](#fig01){ref-type="fig"}). This indicates that ClfA is well-expressed and represents the only Fg-binding protein found at the cell surface of this strain. By means of single-cell force spectroscopy (SCFS; [Fig. 1*C*](#fig01){ref-type="fig"}, *Left*) ([@r22], [@r27][@r28]--[@r29]), we analyzed the ClfA--Fg-binding forces at the whole-cell level. Single bacteria were attached onto colloidal cantilevers, and the forces between the cell probes and Fg substrates were measured. [Fig. 2*A*](#fig02){ref-type="fig"} shows the maximum adhesion forces and rupture lengths obtained for five representative *S. aureus* ClfA^(+)^ cells (for more cells, see [*SI Appendix*, Fig. S1*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)). Most force curves feature adhesion force peaks ranging from ∼1,000 to ∼10,000 pN with rupture lengths of ∼250--300 nm. The characteristics of the curves did not substantially change when recording consecutive force curves on different spots of the substrate, meaning that force measurements did not alter the cell-surface properties. Adhesion forces were spread across a wide range, suggesting that a variable number of molecular bonds were probed. Most adhesive forces were larger than the forces measured for other staphylococcal adhesins ([@r30], [@r31]), suggesting that bacterial adhesion to Fg is very strong. As these large forces were abolished in ClfA^(−)^ cells ([Fig. 2*B*](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S1*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)), we conclude that they mostly reflect specific ClfA--Fg interactions. Most bonds ruptured at ∼250--300 nm, which is consistent with the length of fully unfolded adhesins. Assuming that the processed mature ClfA protein comprises 860 residues, that each amino acid contributes 0.36 nm to the contour length of the polypeptide chain, and that the ClfA folded length is ∼25 nm, we expect that the fully extended ClfA protein should be ∼285 nm long.

![Forces guiding the adhesion of single bacteria to Fg substrates. (*A*) Maximum adhesion force (*Left*) and rupture length (*Right*) histograms with representative retraction force profiles (*Insets*) obtained by recording force-distance curves in PBS between five *S. aureus* ClfA^(+)^ cells from different cultures and Fg substrates. (*B*) Force data obtained in the same conditions for a *S. aureus* ClfA^(−)^ cell. Fluorescence images of the bacterial probes stained with the *BacLight* viability kit (*Insets*) confirmed that the cell membrane is intact even after 30 min of measurements.](pnas.1718104115fig02){#fig02}

How Strong Is the ClfA--Fibrinogen Interaction? {#s3}
-----------------------------------------------

To quantify the strength of single ClfA-Fg bonds we used single-molecule force spectroscopy (SMFS; [Fig. 1*C*](#fig01){ref-type="fig"}, *Right*) ([@r29], [@r32]) with Fg-modified tips. Fg molecules were attached to the tips at low density using a PEG-benzaldehyde linker. In [Fig. 3*A*](#fig03){ref-type="fig"} we present the adhesion force maps, maximum adhesion forces, and rupture lengths obtained between three *S. aureus* ClfA^(+)^ cells and AFM tips functionalized with PEG chemistry (for more cells, see [*SI Appendix*, Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)). Strong adhesion peaks were detected with mean forces of 1,999 ± 267 pN (mean and SD of *n* = 401 adhesive curves), 1,909 ± 155 pN (*n* = 88), and 2,093 ± 68 pN (*n* = 107) for cell \#1, cell \#2, and cell \#3, respectively. Similar adhesion forces were observed when the tips were modified via the NHS chemistry ([Fig. 3*B*](#fig03){ref-type="fig"}), indicating that the detected forces were not dependent on the grafting protocol. Adhesion was mediated by ClfA as it was abrogated in ClfA^(−)^ cells ([Fig. 3*C*](#fig03){ref-type="fig"} and [*SI Appendix*, Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)). Force maps revealed that ClfA was expressed at rather high density and heterogeneously distributed on the cell surface.

![Binding strength of single ClfA--Fg bonds in living *S. aureus* bacteria. (*A*, *Left*) Maximum adhesion force histograms with force maps (*Insets*). (Scale bars: 100 nm.) (*Right*) Rupture length histograms with representative retraction force profiles (*Insets*) obtained by recording force-distance curves in PBS between three different *S. aureus* ClfA^(+)^ cells and AFM tips functionalized with Fg using PEG chemistry. (*B*) Data obtained in the same conditions between two different *S. aureus* ClfA^(+)^ cells and AFM tips functionalized with Fg using NHS chemistry. (*C*) Force data between a *S. aureus* ClfA^(−)^ cell and a AFM tip functionalized with Fg using the PEG chemistry.](pnas.1718104115fig03){#fig03}

We believe that the ∼2-nN forces are associated with single DLL-like interactions for the following reasons. First, for all cells investigated, adhesion forces featured distributions that were narrow and centered near ∼2 nN, which strongly supports the idea that single bonds were probed. When multiple bonds break simultaneously, a wide force range reflecting multiples of the weakest unit force should be observed, which was not the case. Second, forces with very similar sharp distributions were obtained using two different tip chemistries (PEG vs. NHS) that are known to favor single-molecule detection. Third, strong forces are in the range of the strength measured for the DLL interaction between the structurally related SdrG protein and Fg, both on living bacteria ([@r29]) and on purified adhesins ([@r33]). Fourth, we generated an *S. aureus* strain (called ClfA~PY~) expressing ClfA carrying amino acid substitutions within the N2N3-binding trench (P336S and Y338A) that prevents ligand binding by the DLL mechanism. We found that these substitutions almost completely abolished Fg binding to ClfA ([*SI Appendix*, Fig. S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)), thus demonstrating that strong ClfA binding forces are due to a DLL-like interaction.

To study ClfA in the absence of other staphylococcal cell-wall components, we also examined cells from a *Lactococcus lactis* strain expressing ClfA \[*L. lactis* ClfA^(+)^ cells\] ([@r34]). As illustrated in [Fig. 4*A*](#fig04){ref-type="fig"} (for more cells, see [*SI Appendix*, Fig. S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)), this strain featured the same behavior as the *S. aureus* ClfA^(+)^ strain, with strong forces of 2,070 ± 93 pN (mean and SD on *n* = 508 adhesive curves), 1,848 ± 119 pN (*n* = 425), and 1,891 ± 225 pN (*n* = 333) for cell \#1, cell \#2, and cell \#3, respectively. *L. lactis* ClfA^(+)^ cells showed a higher adhesion frequency and sometimes large force values \>2 nN. Whole-cell dot immunoblots ([*SI Appendix*, Fig. S5](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)) suggest that this may be due to a higher expression of the adhesin at the cell surface of *L. lactis* ClfA^(+)^ compared with *S. aureus* ClfA^(+)^.

![ClfA behaves as a force-sensitive molecular switch. (*A*) SMFS data obtained by recording force-distance curves in PBS between Fg tips (PEG chemistry) and three different cells from a model *L. lactis* strain expressing ClfA \[*L. lactis* ClfA^(+)^ cells\]. (Scale bars: 100 nm.) (*B*) Strength of the ClfA--Fg interaction measured at increasing loading rates (*LR*s) on *L. lactis* ClfA^(+)^ cells (4,452 adhesive events from 10 cells). All adhesion peaks were analyzed to take into account all possible interactions. (*C*) The probability of forming strong bonds increases with the *LR.* From the data shown in *B*, discrete ranges of *LR*s were binned, and the force distributions were plotted as histograms ([*SI Appendix*, Fig. S6](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental)). Shown here are the forces observed for low, medium, and high *LR*s.](pnas.1718104115fig04){#fig04}

One may argue that our experiments may not mimic in vivo conditions as Fg was attached to the tip. So we cannot extend our findings on immobilized Fg to conditions where the bacteria may interact with the soluble form of Fg. However, immobilized Fg is biologically relevant as it is associated with blood clots and, importantly, deposited on biomedical device surfaces. Given that the concentration of free Ca^2+^ in blood is equivalent to the IC~50~ for Ca^2+^ to inhibit Fg binding ([@r35]), 50% of ClfA molecules will not have soluble Fg bound and will be free to engage with immobilized Fg in a clot or on a surface.

The ClfA--Fibrinogen Interaction Is Dramatically Enhanced by Tensile Loading. {#s4}
-----------------------------------------------------------------------------

During colonization of host tissues and biomedical devices, *S. aureus* is subjected to physical forces, such as fluid flow and cell-surface contacts ([@r36]). An interesting but poorly understood feature of ClfA is its ability to promote *S. aureus* adhesion under shear stresses ([@r19], [@r37]). We postulated that the ClfA binding strength might be enhanced by mechanical force. To test this, the strength of the ClfA--Fg interaction (*F*) was measured while varying the rate at which force increases (loading rate, *LR*; the effective *LR* was estimated from the force vs. time curves) ([@r38]). [Fig. 4*B*](#fig04){ref-type="fig"} shows that the dynamic force spectroscopy data obtained on *L. lactis* ClfA^(+)^ cells (data pooled from 4,452 adhesive curves on 10 cells) featured a fuzzy distribution with several clouds arising from the different pulling speeds used. Discrete ranges of *LRs* were binned, and the force distributions were plotted as histograms ([*SI Appendix*, Fig. S6](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental), from which [Fig. 4*C*](#fig04){ref-type="fig"} was obtained). Strikingly, we observed a major switch in force distribution with the *LR* ([Fig. 4*C*](#fig04){ref-type="fig"}): when the load was applied slowly, weak forces of 88 ± 69 pN (*n* = 277 events) were detected, whereas at fast *LR* only strong forces of 1,687 ± 180 pN (*n* = 155) were probed. Both weak and strong forces were seen when intermediate *LR*s were used. That strong bonds are favored when the force is increased quickly demonstrates that the strength of the ClfA--Fg interaction is dramatically enhanced with tensile loading.

How does the physical stress applied in AFM compare with that experienced in the body? Undoubtedly, *S. aureus* is exposed to many different levels of shear depending on its location in vivo---from low-shear conditions on implanted biomaterials to high-shear conditions in the blood. The loading rates that bacterial cells experience in biological flowing fluids can exceed 100,000 pN/s ([@r39]). So our results showing that a *LR* of 10,000 pN/s is sufficient to favor strong binding suggest that force-induced ClfA adhesion will occur in vivo in a number of situations.

Finally, we asked whether weak and strong forces could be associated with two distinct binding sites. Previous studies have shown that Fg binding involves a DLL interaction between the trench of ClfA N2N3 subdomains and the extreme C terminus of the γ-chain of Fg ([@r11], [@r13]). We therefore tested the ability of a short γ-chain peptide to block the adhesive forces of *L. lactis* ClfA^(+)^ cells. [Fig. 5](#fig05){ref-type="fig"} and [*SI Appendix*, Fig. S7](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental) show that incubation of *L. lactis* ClfA^(+)^ cells with the γ-chain peptide led to a dramatic inhibition of high forces while leaving low forces essentially unchanged. This means that strong forces, but not weak ones, are due to DLL binding between the ClfA trench and the Fg γ-chain. This finding supports a two-site mechanism and provides a direct confirmation of earlier observations that, in addition to the γ-peptide--binding trench, there is a second binding site located at the top of the N3 domain that is critical for an overall high-affinity Fg--ClfA interaction ([@r13], [@r40]).

![Adhesion to Fg involves two ClfA-binding sites. (*A* and *B*) Adhesion forces obtained by recording force-distance curves in PBS between three different *L. lactis* ClfA^(+)^ cells and Fg tips in the absence (*A*) or presence (*B*) of the C-terminal segment of the Fg γ-chain (0.2 mg⋅mL^−1^). All adhesion peaks were analyzed to take into account all possible interactions.](pnas.1718104115fig05){#fig05}

Discussion {#s5}
==========

ClfA is an important virulence factor of *S. aureus* that binds to Fg-coated biomaterials. This adhesin favors bacterial adhesion under high physical stress, but how this is achieved at the molecular level is not known. We have demonstrated that ClfA is a force-sensitive molecular switch that activates adhesion of *S. aureus* to Fg-conditioned surfaces under high mechanical forces. Our results emphasize the role of mechanobiology in regulating *S. aureus* adhesion and may contribute to the development of antiadhesion strategies using soluble inhibitors.

To understand the molecular origin of the force-induced strengthening of the ClfA--Fg bond, we recall that theory predicts---and experiments confirm---that unbinding force between receptors and ligands increases with the rate at which force is applied. The Bell--Evans theory ([@r41]) describes a log linear relationship between the *LR* and the rupture force. More recently, Friddle et al. ([@r42]) developed a model that adequately describes nonlinear trends in rupture forces, considering that nonlinearity arises either through the reforming of a single bond at slow loading rates or as a consequence of asynchronous fluctuations of several independent interactions. So current models and data all show continuous increases in rupture force with the *LR*. By contrast, the ClfA--Fg bond features an unusual switch in force distribution; that is, weak bonds (∼100 pN) dominate at low *LR* while strong bonds (∼1,500 pN) are favored at high *LR*. Because the strengths of weak and strong bonds differ by an order of magnitude and intermediate forces were rarely observed, we believe that strong bonds do not result from the simultaneous rupture of multiple weak bonds.

We propose that the unusual force-dependent strengthening of the ClfA--Fg bond involves a force-induced conformational change in the adhesin, from a weak- to a strong-binding state. That the γ-chain peptide of Fg inhibits high forces but not low forces favors a two binding site model, where the activity of the two binding sites is tightly regulated by tensile force ([Fig. 6](#fig06){ref-type="fig"}). Under low tensile force, Fg binds to the top of the ClfA N3 domain via weak bonds. Under high mechanical tension, extension and conformational changes in the ClfA molecule trigger the ultrastrong DLL interaction by the N2N3 subdomains. Such a mechanism may help us to identify soluble ligands capable of inhibiting bacterial adhesion under high flow conditions.

![Proposed model for the force-activated adhesion of ClfA. (*Left*) Under low mechanical force, Fg weakly binds to the top of the ClfA N3 domain. (*Right*) Under high force, extension and conformational changes of the ClfA N2N3 subdomains enable the γ-chain of Fg to dock in the ligand-binding trench and form strong DLL-like interactions.](pnas.1718104115fig06){#fig06}

The force-dependent ClfA--Fg interaction is reminiscent of a catch-bond behavior, that is, a specific bond that is reinforced by mechanical stress ([@r43]). A well-documented example is the *E. coli* FimH adhesin that binds mannose residues on epithelial cells ([@r39]). The FimH--mannose bond is weak and relatively short lived at low flow, whereas this bond is strengthened at high flow. This is explained by an allosteric model in which tensile mechanical force induces an allosteric switch from a low- to a high-affinity conformation of the adhesin ([@r43], [@r44]). Perhaps the ClfA--Fg interaction involves such an allosterically controlled mechanism, whereby stretching of the subdomains would suppress allosteric interplay and trigger strong DLL binding.

The strength of the ClfA bond at high tensile load is in the range of that of covalent bonds, despite a moderate affinity value ([@r8][@r9]--[@r10]). This discrepancy suggests that the unbinding pathway of the adhesin may change when mechanical force is applied ([@r45]). So, when studying the mechanisms of bacterial adhesion under physiological shear, force measurements performed at nonequilibrium might be more relevant than equilibrium assays. That the ClfA--Fg complex resists very high forces is counterintuitive as rupture of the polypeptide backbones is expected to occur first. A possible explanation is that the complex may direct force along pathways nonparallel to the pulling direction, as shown for the mechanically stable multidomain cellulosome protein complex ([@r45]).

The high binding strength provides a molecular framework to explain how ClfA promotes *S. aureus* adhesion on blood protein-coated surfaces under high shear stress conditions ([@r19], [@r37]). Fg binding to ClfA expressed on the surface of *S. aureus* or *L. lactis* facilitates platelet capture and thrombus formation under high shear conditions but not when low shear rates are applied ([@r19], [@r37]). ClfA binding to Fg under shear conditions creates a bridge between the bacterium and integrin receptors expressed by endothelial cells ([@r46]). In addition, ClfA is involved in the shear-dependent adhesion of *S. aureus* to von Willebrand factor, thereby allowing the bacteria to resist shear forces of flowing blood ([@r20], [@r21]). It is possible that *S. aureus* has evolved force-dependent adhesion mechanisms such as the one unraveled here to help the bacteria resist physical stress during host colonization, whereas weak adhesion forces at low shear stress would favor cell detachment and thus the colonization of new sites.

Methods {#s6}
=======

*S. aureus* ClfA^(−)^ is a *S. aureus* SH1000 *clfA clfB fnbA fnbB* strain defective in both clumping factors A and B and fibronectin-binding proteins A and B ([@r26]) whereas *S. aureus* ClfA^(+)^ is SH1000 *clfA clfB fnbA fnbB* transformed with the plasmid pALC2073::*clfA* ([@r47]). To study the effect of amino acid substitutions within the N2N3-binding trench, we used *S. aureus* ClfA~WT~, which is SH1000 *clfA clfB fnbA fnbB* carrying the plasmid pCF77 expressing ClfA from its own promoter ([@r48]), and *S. aureus* ClfA~PY~, which is the same strain with P336S and Y338A substitutions in the N2 subdomain of ClfA ([@r49]). Growth conditions and AFM methods are described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1718104115/-/DCSupplemental).
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